< Back to previous page

Patent

Treatment of epilepsy

The present invention discloses isoquinolines and 1H-2-Benzopyranes and their use in the treatment and prevention in epilepsy and other seizures. The present invention further discloses methods to screen isoquinoline- and 1H- 2-Benzopyran- like molecules as pharmaceutically active compounds.
Patent Publication Number: EP3675855
Year filing: 2020
Year approval: 2021
Year publication: 2020
Status: Requested
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven